company background image
INCR logo

InterCure NasdaqGM:INCR Stock Report

Last Price

US$1.35

Market Cap

US$61.8m

7D

15.4%

1Y

18.9%

Updated

22 Nov, 2024

Data

Company Financials

INCR Stock Overview

Engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. More details

INCR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

InterCure Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for InterCure
Historical stock prices
Current Share Price₪1.35
52 Week High₪3.72
52 Week Low₪1.12
Beta0.033
11 Month Change-23.59%
3 Month Change-36.02%
1 Year Change18.94%
33 Year Change-80.99%
5 Year Change-3.57%
Change since IPO-46.22%

Recent News & Updates

InterCure: A Cannabis Industry Leader Still Flying Under The Radar

Jun 30

InterCure: Bargain Israel Cannabis Play

Apr 22

Recent updates

InterCure: A Cannabis Industry Leader Still Flying Under The Radar

Jun 30

InterCure: Bargain Israel Cannabis Play

Apr 22

InterCure: A Leader In Global Cannabis

Sep 06

InterCure reports Q2 results

Aug 15

InterCure Is Growing In The Massive Global Cannabis Market

Jun 07

IntureCure: Israel Recreation Cannabis Boom On The Way

Feb 16

InterCure Chairman Ehud Barak, CEO Alex Rabinovitch - Israel Cannabis And Beyond (Video)

Nov 08

InterCure: Internationally Profitable Cannabis (Podcast Transcript)

Sep 19

InterCure: Ignored Uplisting

Sep 09

Shareholder Returns

INCRUS PharmaceuticalsUS Market
7D15.4%1.6%2.2%
1Y18.9%10.0%31.7%

Return vs Industry: INCR exceeded the US Pharmaceuticals industry which returned 10.8% over the past year.

Return vs Market: INCR underperformed the US Market which returned 31.1% over the past year.

Price Volatility

Is INCR's price volatile compared to industry and market?
INCR volatility
INCR Average Weekly Movement10.1%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.3%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: INCR's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: INCR's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1994270Alex Rabinovichwww.intercure.co

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.

InterCure Ltd. Fundamentals Summary

How do InterCure's earnings and revenue compare to its market cap?
INCR fundamental statistics
Market capUS$61.76m
Earnings (TTM)-US$17.71m
Revenue (TTM)US$73.57m

0.8x

P/S Ratio

-3.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
INCR income statement (TTM)
Revenue₪272.67m
Cost of Revenue₪194.70m
Gross Profit₪77.98m
Other Expenses₪143.60m
Earnings-₪65.62m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.43
Gross Margin28.60%
Net Profit Margin-24.07%
Debt/Equity Ratio28.8%

How did INCR perform over the long term?

See historical performance and comparison